Benzinga’s Top Pre-Market NASDAQ Losers (JAZZ, SAFM, PDLI, COCO)

Jazz Pharmaceuticals Inc JAZZ dipped 25.22% to $7.65 in the pre-market session. US FDA panel has rejected JAZZ’s drug for treating the pain disorder fibromyalgia. Sanderson Farms Inc SAFM lost 4.56% to $41.19 in the pre-market session. SAFM has reported weaker-than-expected Q3 results. PDL BioPharma Inc PDLI fell 2.76% to $5.29 in the pre-market session. PDLI’s quarterly earnings dipped 35.10% y/y. Corinthian Colleges Inc COCO slipped 2.00% to $4.40 in pre-market trading. Analysts at ThinkEquity Partners downgraded COCO from “buy” to “hold.” Read more from Benzinga's Company news.